NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference32 articles.
1. Keynote comment: why the lack of progress for oral cancer?;Shah;Lancet Oncol.,2006
2. Number of deaths and proportional mortality rates from malignant neoplasms by site in Japan (2003);Nomura,2005
3. Reassessment of the role of induction chemotherapy for head and neck cancer;Gibson;Lancet Oncol.,2006
4. Dysregulated molecular networks in head and neck carcinogenesis;Molinolo;Oral Oncol.,2009
5. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma;Ha;Lancet Oncol.,2006
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biological and prognostic significance of NDRG2 downregulation in oral squamous cell carcinoma;Oral Diseases;2024-06-17
2. Genome‐wide DNA methylation profiling in tongue squamous cell carcinoma;Oral Diseases;2022-12-02
3. Phosphoproteomic analysis of the AKT signalling axis in cutaneous squamous carcinoma progression reveals novel therapeutic targets;2022-10-05
4. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway;Bioengineered;2021-12-24
5. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer;Pharmacological Research;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3